Return to Main MenuContact Us
Anemia May Affect Many of Your Patients on Chemotherapy
According to a comprehensive review of published chemotherapy trials of common single-agent
and combination chemotherapy regimens:
Up to 97% of Your Patients Receiving Myelosuppressive Chemotherapy May Be Anemic1
|
Definitions of Anemia
|
|
Grading System for Anemia According to Hemoglobin Level1
|
|
Severity
|
World Health Organization
|
National Cancer Institute
|
|
Grade 2 (moderate)
|
8.0-9.4 g/dL
|
8.0-10.0 g/dL
|
|
Grade 3 (serious/severe)
|
6.5-7.9 g/dL
|
6.5-7.9 g/dL
|
|
Grade 4 (life-threatening)
|
< 6.5 g/dL
|
< 6.5 g/dL
|
1.Groopman JE, Itri LM. Chemotherapy-induced anemia
in adults: incidence and treatment. J Natl Cancer Inst. 1999;91(19):1616-1634.
Helpful Resources You May Be Interested In:
Contact Us